We can make clinical research better for everyone!

Joined June 2011
185 Photos and videos
James Watson was a bad guy and carried himself terribly, especially around female peers, and that’s how he should be remembered.
1
26
AdamJButler retweeted
20 May 2025
Join academic, industry, and regulatory global leaders at the ISCTM/ECNP Joint Autumn Conference to address challenges and future directions in CNS trials! Amsterdam, Netherlands 9-11 October isctmautumn.societyconferenc… #ISCTM #ECNP #CNS #trials #methodology
2
2
228
AdamJButler retweeted
Instead of an election let’s just see who can draw a clock better
67
957
10,556
398,236
Today I learned that “Versorgungsrealität” is the German word for standard of care.
95
“If sponsors do not own the data used for the external control arm, they should structure their agreements with the data owners to ensure that patient-level data can be provided to FDA in support of the marketing application.” fda.gov/media/164960/downloa…

1
1
145
The draft guidance on external controls is really interesting. IP issues on secondary data usage in pharma are already complicated. RWE market is now a fight for as much analyzable data as possible.
101
Amy Abernathy at @CNSSummit “we need to make sure these technologies work for site coordinators.” Coordinators are the true workhorses of clinical trials!
1
1
3
Placebo response is a methodology problem: “Paradoxical results were observed in certain study sites, where placebo dramatically outperformed REL-1017. Relmada is investigating the nature of these results.” relmada.com/investors/news/p…

Reviewing a pitch from a health tech startup. Under “Science & Outcomes” are three “lorem ipsum” bullets 🧐
1
1
Karuna answers the question “can you rehabilitate a failed drug by designing better studies?” with a definitive yes. Managing placebo response in this population is hard, and this data shows clear signals of improvement. investors.karunatx.com/news-…

This is a huge issue - I’m certain the attrition rates on lots of app-based treatments are high. But it’s also important to consider that adherence to pharmacological treatment for patients with psych conditions is around 50%. statnews.com/2022/08/02/pear…
Rune Labs news is really interesting. I wonder - are they collecting raw data from the Apple Watch and analyzing it for tremors, or simply reporting the Apple data through Health Kit? statnews.com/2022/06/13/appl…
1
What a blockbuster from @bddol - FDA leadership overrode an internal review to grant Apple’s Afib device a de novo exitsandoutcomes.com/who-con…
1
1
7
Having Janet Woodcock take responsibility for the Office of Digital Transformation will be a huge win for adoption of new technology in trials
19 May 2022
FDA commissioner Rob Califf told staff that longtime drug center director Janet Woodcock, who’s serving as his principal deputy, would take on more of a role as “a strategic thought partner, with decision-making authorities” at several offices within FDA. endpts.com/fda-commissioner-…
1
4
Repeated sickle cell failures feels similar to neuro and psych failures - no great or consistent biomarkers, noisy primary outcome measures, low effect sizes. Huge opportunity to introduce meaningful digital measures. globenewswire.com/news-relea…
When the FDA COA office rejected Verily's VME, they specified finger-tapping as not meaningful. In this paper just published by FDA CDRH, they use finger-tapping as an example of a possible digital biomarker. nature.com/articles/s41746-0…
1
1
Footnote says "These are theoretical examples. The authors do not assert that hand tapping would be a measure of hand function/dexterity without appropriate evaluation of the analytical and clinical evidence." It seems confusing to include this example.